TY - JOUR T1 - Repeat adverse drug events associated with outpatient medications: a descriptive analysis of 3 observational studies in British Columbia, Canada JF - CMAJ Open JO - CMAJ SP - E446 LP - E453 DO - 10.9778/cmajo.20180190 VL - 7 IS - 3 AU - Corinne M. Hohl AU - Stephanie A. Woo AU - Amber Cragg AU - Maeve E. Wickham AU - Christine Ackerley AU - Frank Scheuermeyer AU - Diane Villanyi Y1 - 2019/07/01 UR - http://www.cmajopen.ca/content/7/3/E446.abstract N2 - Background: Adverse drug events are an important cause of preventable emergency department visits and hospital admissions. We examined repeat adverse drug events associated with outpatient medications resulting in acute care utilization.Methods: This descriptive analysis combined data from 3 prospective multicentre observational studies, in which clinical pharmacists and physicians independently evaluated patients who visited the emergency department for adverse drug events in 3 hospitals in British Columbia. During these studies, an independent committee adjudicated all discordant and uncertain cases using a standardized algorithm. For the current study, we retrospectively reviewed the medical and research records of all patients 19 years of age and older who had been diagnosed with an adverse drug event during the primary studies to determine the proportion of repeat events. We used multivariable logistic regression to identify factors associated with repeat events; we adjusted for clustering at the hospital level for patient-level analyses and at the patient level for event-level analyses.Results: Among 12 977 patients, 1178 were diagnosed with 1296 adverse drug events at the point of care. Of these events, 32.5% (421 of 1296; 95% confidence interval [CI] 29.8%–35.1%) were repeat events, of which 75.3% (317 of 421; 95% CI 71.1%–79.5%) were deemed probably or definitely preventable as re-exposure to the culprit medication or repeat withdrawal of an indicated medication was inconsistent with best medical practice. Patients presenting with repeat events were more likely to have renal failure (odds ratio [OR] 2.01; 95% CI 1.32%–3.07%) or a mental health diagnosis (OR 1.39; 95% CI 1.02%–1.88%).Interpretation: A high proportion of adverse drug events were repeat events, most of which were deemed preventable. Interventions to ensure that care providers are aware of previously diagnosed adverse drug events when prescribing or dispensing need to be developed and evaluated and may reduce unintentional re-exposures to previously harmful medications. ER -